Khemla, S., A. Meesing, W. Sribenjalux, and P. Chetchotisakd. “Lipid Profiles of People With Human Immunodeficiency Virus With Dyslipidemia After Switching from Efavirenz to Dolutegravir”. Drug Target Insights, vol. 17, no. 1, Apr. 2023, pp. 45-53, doi:10.33393/dti.2023.2529.